Treatment of Multinodular Goiter by Surgery

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2002 Jan 5

PMID 11765054

Citations 1

Authors

L J DeGroot

Affiliations

Soon will be listed here.

Citing Articles

Prospective analysis of risk for hypothyroidism after hemithyroidectomy.

Beisa V, Kazanavicius D, Skrebunas A, Simutis G, Ivaska J, Strupas K Int J Endocrinol. 2015; 2015:313971.

PMID: 25918526 PMC: 4396907. DOI: 10.1155/2015/313971.

References

Koornstra J, Kerstens M, Hoving J, Visscher K, Schade J, Gort H . Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs. Neth J Med. 1999; 55(5):215-21. DOI: 10.1016/s0300-2977(99)00066-2. View

Netterville J, Coleman S, Smith J, Smith M, Day T, Burkey B . Management of substernal goiter. Laryngoscope. 1998; 108(11 Pt 1):1611-7. DOI: 10.1097/00005537-199811000-00005. View

Huysmans A, Hermus R, Edelbroek M, TJABBES T, Oostdijk , Ross H . Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid. 1997; 7(4):535-9. DOI: 10.1089/thy.1997.7.535. View

de Klerk J, van Isselt J, van Dijk A, Hakman M, Pameijer F, Koppeschaar H . Iodine-131 therapy in sporadic nontoxic goiter. J Nucl Med. 1997; 38(3):372-6. View

Nygaard B, Hegedus L, Ulriksen P, Nielsen K, Hansen J . Radioiodine therapy for multinodular toxic goiter. Arch Intern Med. 1999; 159(12):1364-8. DOI: 10.1001/archinte.159.12.1364. View

Hegedus L, Nygaard B, Hansen J . Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified?. J Clin Endocrinol Metab. 1999; 84(2):756-60. DOI: 10.1210/jcem.84.2.5478. View

Delbridge L, GUINEA A, Reeve T . Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg. 1999; 134(12):1389-93. DOI: 10.1001/archsurg.134.12.1389. View

Banchuin C, Panpimarnmas S . Effect of post-operative thyroid hormone therapy on the recurrence of benign thyroid nodules. A study in Thai patients. J Med Assoc Thai. 1998; 80(11):715-9. View

Edmonds C, Smith T . The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol. 1986; 59(697):45-51. DOI: 10.1259/0007-1285-59-697-45. View

10.

Huysmans D, Buijs W, van de Ven M, Van Den Broek W, KLOPPENBORG P, Hermus A . Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters. J Nucl Med. 1996; 37(12):2072-9. View

11.

Pappalardo G, Guadalaxara A, Frattaroli F, Illomei G, Falaschi P . Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg. 1998; 164(7):501-6. DOI: 10.1080/110241598750005840. View

12.

Howarth D, Epstein M, Thomas P, Allen L, AKERMAN R, Lan L . Outpatient management of patients with large multinodular goitres treated with fractionated radioiodine. Eur J Nucl Med. 1998; 24(12):1465-9. DOI: 10.1007/s002590050175. View

13.

Le Moli R, Wesche M, Wiersinga W . Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol (Oxf). 1999; 50(6):783-9. DOI: 10.1046/j.1365-2265.1999.00734.x. View

14.

Hall P, Holm L, Lundell G, Bjelkengren G, Larsson L, Lindberg S . Cancer risks in thyroid cancer patients. Br J Cancer. 1991; 64(1):159-63. PMC: 1977300. DOI: 10.1038/bjc.1991.261. View

15.

Dietlein M, Lauterbach K, Schicha H . Treatment of toxic nodular goitres: Comparative costing of radioiodine therapy and surgery. Exp Clin Endocrinol Diabetes. 1998; 106 Suppl 4:S66-70. DOI: 10.1055/s-0029-1212061. View

16.

Bonnema S, Bertelsen H, Mortensen J, Andersen P, Knudsen D, Bastholt L . The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab. 1999; 84(10):3636-41. DOI: 10.1210/jcem.84.10.6052. View